|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
0.990 +0.040 (+4.211%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 981,824 | -14.040% | 1,142,184 | 1,108,747 | 1,026,451 | 197,557 |
| Cost of Sales | (642,679) | -12.705% | (736,216) | (763,775) | (710,176) | (97,439) |
| Gross Profit | 339,145 | -16.460% | 405,968 | 344,972 | 316,275 | 100,118 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 59,740 | 337.271% | 13,662 | (5,051) | 45,997 | (549,302) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (321) | |
| Profit / (Loss) before Taxation | 185,516 | 404.778% | 36,752 | (63,474) | 122,054 | (522,393) | |
| Taxation | (41,279) | 78.751% | (23,093) | (21,746) | (26,252) | (7,879) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (27,429) | 116.899% | (12,646) | (5,981) | (10,782) | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 116,808 | 11430.898% | 1,013 | (91,201) | 85,020 | (530,272) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 22,346 | -70.062% | 74,640 | 78,186 | 79,926 | 30,743 |
| Depreciation & Amortisation | 101,601 | -3.940% | 105,768 | 87,254 | 68,298 | 21,105 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 5.000 | 4900.000% | 0.100 | -5.000 | 4.000 | -38.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 1.503 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.753 | -- | 1.665 | 1.775 | 1.726 | 1.126 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 116,808,000 |
| %Change | 11430.898% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 1.753 |